January 03, 2026 — RNews

#atopic dermatitis — Saturday, January 03, 2026 (1 items)

hot top new

← prev day next day →

0

Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials. (linkinghub.elsevier.com)

Guttman-Yassky E … Bissonnette R The Lancet 2026-01-03

#inflammation #clinical trial #immunotherapy #atopic dermatitis